Paul Ehrlich Institute

Paul Ehrlich Institute
	Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
Agency overview
Formed	1 June 1896
Jurisdiction	Government of Germany
Headquarters	Langen, Hesse, Germany
Employees	793
Agency executive	Klaus Cichutek, President;
Website	www.pei.de

The Paul Ehrlich Institute (German: Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, PEI) is a German research institution and medical regulatory body, and is the German federal institute for vaccines and biomedicines. It is a federal agency and subordinate to the Federal Ministry of Health. It is a WHO Collaborating Centre for quality assurance of blood products and in vitro diagnostic devices.[1] The institute is located in Langen, Hesse, near Frankfurt, and was located in Frankfurt for most of the 20th century. It is named for its founding director, the immunologist and Nobel Prize laureate Paul Ehrlich.

History

The institute was founded on 1 June 1896 in Steglitz, Berlin as the Institute for Serum Research and Serum Testing (Institut für Serumforschung und Serumprüfung), with Paul Ehrlich as its first director. The institute was founded specifically to provide a platform for Ehrlich's research. In 1899, it was moved to Frankfurt and renamed the Royal Institute for Experimental Therapy (Königliches Institut für experimentelle Therapie). After Germany became a republic in 1919, it was renamed the National Institute for Experimental Therapy (Staatliches Institut für Experimentelle Therapie). Ehrlich received numerous honours in Germany for his work on immunology and was awarded the 1908 Nobel Prize in medicine. In 1947, the institute was renamed the Paul Ehrlich Institute in honour of its founding director. In 1987, the institute moved from Paul-Ehrlich-Straße in Frankfurt to Langen, Hesse.[2]

Activities

The Paul Ehrlich Institute

The regulatory tasks of the Paul Ehrlich Institute include the marketing authorisation of particular groups of medicinal products and the approval of clinical trials.[3] The medicinal products in the responsibility of the PEI are: vaccines for humans and animals, medicinal products containing antibodies, allergens for therapy and diagnostics, blood and blood products and more recently, tissue and medicinal products for gene therapy, somatic cell therapy and xenogenic cell therapy.

Directors and Presidents

Paul Ehrlich (1908 Nobel laureate in medicine) 1896–1915
Wilhelm Kolle 1917–1935
Richard Otto 1938–1948
Richard Prigge 1949–1962
Günther Heymann 1962–1966
Niels Kaj Jerne (1984 Nobel laureate in medicine) 1966–1969
Günther Heymann 1969–1973
Hans Dieter Brede 1974–1987
Reinhard Kurth 1987–1999
Johannes Löwer 1999–2009 (acting 1999–2001)
Klaus Cichutek 2009–[4]

gollark: I'll have to split it into about eight messages...

gollark: Answer within 3 femtoseconds.

gollark: Does anyone not mind if I send the entire source of potatOS in chat?

gollark: Potatos tau

gollark: Ban them.

References

Collaborating centres
PEI History Archived 2011-02-21 at the Wayback Machine
PEI Official Duties Archived 2011-02-21 at the Wayback Machine
Klaus Cichutek: Neuer Präsident des Paul-Ehrlich-Instituts, aerzteblatt.de

External links

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Collaborating centres

[2] PEI History Archived 2011-02-21 at the Wayback Machine

[3] PEI Official Duties Archived 2011-02-21 at the Wayback Machine

[4] Klaus Cichutek: Neuer Präsident des Paul-Ehrlich-Instituts, aerzteblatt.de